Ac-PGP trifluoroacetate salt hydrate
SIGMA/A2112 - ≥98% (HPLC)
Synonym: 1-
CAS Number: 292171-04-1 (free base)
Empirical Formula (Hill Notation): C14H21N3O5 · xC2HF3O2 · yH2O
Molecular Weight: 311.33 (anhydrous free base basis)
MDL Number: MFCD20134196
Linear Formula: C14H21N3O5 · xC2HF3O2 · yH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C14H21N3O5.C2HF3O2.H2O |
| InChI key | UCOFOXNKITYGTK-ULEGLUPFSA |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | O.OC(=O)C(F)(F)F.CC(=O)N1 |
| solubility | deionized water: ≥2 mg/mL |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Ac-PGP is a neutrophil chemoattractant. |
| Biochem/physiol Actions: | N-acetyl Proline-Glycine-Proline (ac-PGP) is a potent and selective neutrophil chemoattractant. It is generated enzymatically from extracellular matrix proteins such as collagen. PGP is generated from native collagen by the action of matrix metalloproteinase–8 (MMP-8) and/or MMP-9, followed by a secondary cleavage by prolyl endopeptidase (PE). N-terminal acetylation of PGP (Ac-PGP) occurs through an unknown mechanism. Both PGP and AcPGP are considered biomarkers and possible therapeutic targets for chronic obstructive pulmonary disease (COPD) and may also be markers for acute pulmonary exacerbation in Cystic Fibrosis. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


